The administration of nivolumab, an anti-PD-1 antibody preparation, to squamous cell carcinoma patients, who were found to be positive for hepatitis C virus antibodies, caused an acute exacerbation of hepatitis C with an increase in plasma ALT values. This evidence concerns the gene GPT and hepatitis C virus infection.